Antibiotics With Promise
Antibiotics: The term antibiotic resistance or drug resistance is a subset of antimicrobial resistance or AMR which is the ability of a microbe to resist the effects of medication. AMR is facilitated by the inappropriate use of medicines, for example, using antibiotics for viral infections such as the flu. Recently, the United Nations (UN) has begun considering the threat of antimicrobial resistance (AMR) to be at par with diseases like Ebola and HIV.
Recently, some Indian researchers developed the antibiotic Cefepime/Zidebactam to combat drug resistance of pathogens.
Cefepime/Zidebactam, developed by Indian researchers is an antibiotic that combines two active components to combat drug resistant gram-negative pathogens, including Pseudomonas aeruginosa. Gram-negative bacteria are resistant to multiple drugs and are increasingly resistant to most available antibiotics. These bacteria have built-in abilities to find new ways to be resistant and can pass along genetic materials that allow other bacteria to become drug-resistant as well.
This Indian innovation has shown remarkable potential, when given to an 18year old patient suffering from T-cell leukemia it showed positive signs such as the patient’s fever subsided, blood cultures turned negative, and the need for oxygen diminished, slowly but steadily, his strength returned, reigniting hope.
Cefiderocol, developed by a Japanese company has demonstrated excellent efficacy against drug-resistant infections. The drug is being licensed in many countries but not in India.
India has not given Emergency Use Authorization (EUA) to these drugs.
EUA is a mechanism to facilitate the availability and use of medical countermeasures, including vaccines, during public health emergencies such as the COVID-19 pandemic. It is opposite to the conventional method of drug approval.
In India, the regulatory authority is the Central Drugs Standard Control Organisation (CDSCO).
Cefepime/zidebactam is a shining example of India’s scientific skill by demonstrating its potential to save lives. The inclusion of Cefepime/zidebactam and Cefiderocol in the EUA list would not only empower doctors but also instill a renewed sense of hope and confidence among patients and their families.
Follow US | |
UPSC Govt. Jobs UPSC Current Affairs UPSC Judiciary PCS Download Adda 247 App here to get the latest updates |
Antimicrobial resistance (AMR) refers to the ability of microorganisms to resist the effects of medications, particularly antibiotics. It is facilitated by the inappropriate use of medicines, such as using antibiotics for viral infections.
Antimicrobial resistance poses a threat to millions of lives as potent antibiotics to combat drug-resistant infections become scarce. The effectiveness of available antibiotics has diminished due to rising resistance, leading to the need for sub-optimal treatments with potential side effects.
Cefepime/Zidebactam is an antibiotic developed by Indian researchers. It combines two active components to combat drug-resistant gram-negative pathogens, including Pseudomonas aeruginosa. Gram-negative bacteria are known for their resistance to multiple drugs, and this innovation shows promise in combating their resistance.
The UKPSC Admit Card 2024 has been declared by Uttarakhand Public Service Commission (UKPSC) on the official…
Being an IAS officer involves significant responsibility, accompanied by a favorable salary package. IAS officers…
The highly reputed exam of India "UPSC" is conducted every year to recruit for the…
The Uttar Pradesh Public Service Commission (UPPSC) conducts the UPPSC Exam annually. UPPSC Salary 2024…
Jharkhand Judiciary Prelims Result 2024 Out: The High Court of Jharkhand has released the Jharkhand…
The Union Public Service Commission has released the UPSC EPFO PA Admit Card 2024 on…